MIKROBE Management of Infected Knee Replacements-Obtaining Best Evidence (MIKROBE)

November 15, 2023 updated by: Royal Devon and Exeter NHS Foundation Trust

MIKROBE Management of Infected Knee Replacements-Obtaining Best Evidence A Feasibility Study for a Randomised Controlled Trial of One-stage or Two-stage Surgery for Prosthetic Knee Infection

Following a prosthetic knee joint infection, two types of operative approach can be undertaken to treat the infection: a one-stage or two-stage revision operation. Both approaches are widely used and are good at treating infection but we don't know which has the best long-term outcomes for patients. This trial aims to assess the feasibility of conducting a randomised controlled trial to evaluate whether treating a prosthetic knee infection with one-stage revision surgery gives a better outcome than two-stage revision surgery in terms of patient function and pain, and cost-effectiveness.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oxford, United Kingdom
        • Nuffiels Orthopaedic Centre (NOC)
    • Devon
      • Exeter, Devon, United Kingdom, EX2 5DW
        • Princess Elizabeth Orthopaedic Centre, Royal Devon and Exeter NHS Trust (RD&E NHSFT)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults with prosthetic knee infection suitable for either one-stage or two-stage revision surgery
  • Intra-operatively, all cases must have adequate soft-tissue coverage post debridement to allow single or two stage revision surgery.
  • Case meets the International Consensus Meeting criteria for infection
  • Patients having had a Debridement, Anti-biotic and Implant Retained procedure previously or washout/biopsy only of an infected TKR are suitable

Exclusion Criteria:

  • Unable or unwilling to undergo either treatment
  • Lacking capacity to consent to research
  • Refusal to consent to study for any reason
  • Re-revision of prosthetic knee infection if first revision was for infection
  • Presence of tuberculosis infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: One-stage
A one-stage revision operation involves one operation to remove the joint, thoroughly cleaning the infected area and then implanting a new joint immediately.
Active Comparator: Two-stage
A two-stage revision operation involves two operations: the joint is removed in one operation, a temporary spacer device is inserted, then the infection is treated with antibiotics, and then a new joint is implanted in a second operation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ease of recruitment of participants
Time Frame: 20 months
Number of recruits compared to the number of potential participants.
20 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Explaining the study
Time Frame: 20 months
Assessment of the process of explaining the study (explanation/recruitment/randomisation) between patients and surgeons via qualitative analysis of audio recording of pre-operative discussions about entering the study.
20 months
Reasons for non-participation
Time Frame: 20 months
Qualitative analysis of semi-structured interviews with those patients who declined to participate in the trial.
20 months
Patient experience
Time Frame: 2 weeks after surgery
Experience and acceptability of the process of recruitment, randomisation and study participation via qualitative analysis of semi-structured interview.
2 weeks after surgery
Surgeon experience
Time Frame: 20 months
Experience of the process of recruitment, randomisation and study participation including thoughts about trial design via qualitative analysis of semi-structured interview after each patient surgery and at the end of the trial.
20 months
Protocol adherence
Time Frame: 20 months
Assessment of any deviations or violations to protocol that occur during the trial.
20 months
Healthcare resource utilisation
Time Frame: 20 months
Patient-reported questionnaire assessing heath and social resource use through an adapted questionnaire of the Client Service Receipt Inventory (CSRI) at 3 and 6 months post-operatively
20 months
Comparison of two sites
Time Frame: 20 months
Recruitment and attrition rates at the two sites
20 months
Knee injury and Osteoarthritis Outcome Score (KOOS) outcome and completion rates
Time Frame: 20 months
Patient-reported questionnaire assessing short-term and long-term symptoms and function in patients with knee injury to be administered pre-, 3 months and 6 months post-operatively
20 months
Oxford Knee Score (OKS) outcome and completion rates
Time Frame: 20 months
Patient-reported questionnaire assessing function and pain after total knee replacement surgery to be administered pre-, 3 months and 6 months post-operatively
20 months
EQ-5D-5L outcome and completion rates
Time Frame: 20 months
Patient-reported questionnaire assessing health-related quality of life to be administered pre-, 3 months and 6 months post-operatively
20 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrew Toms, FRCS, Royal Devon and Exeter NHS Foundation Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 17, 2020

Primary Completion (Actual)

January 30, 2023

Study Completion (Actual)

January 30, 2023

Study Registration Dates

First Submitted

June 5, 2020

First Submitted That Met QC Criteria

July 6, 2020

First Posted (Actual)

July 7, 2020

Study Record Updates

Last Update Posted (Estimated)

November 16, 2023

Last Update Submitted That Met QC Criteria

November 15, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthroplasty, Replacement, Knee

Clinical Trials on One-stage

Subscribe